Test Code PBUOE Lead Occupational Exposure, Random, Urine
Ordering Guidance
The Centers for Disease Control and Prevention recommends venous blood collection for lead testing; see PBDV / Lead, Venous, with Demographics, Blood.
Specimen Required
Patient Preparation: High concentrations of gadolinium and iodine are known to interfere with most metal tests. If either gadolinium- or iodine-containing contrast media has been administered, a specimen should not be collected for 96 hours.
Supplies: Urine Tubes, 10 mL (T068)
Collection Container/Tube: Clean, plastic urine container with no metal cap or glued insert
Submission Container/Tube: Plastic vial or clean, plastic aliquot container with no metal cap or glued insert
Specimen Volume: 3 mL
Collection Instructions:
1. Collect a random urine specimen.
2. See Metals Analysis Specimen Collection and Transport for complete instructions.
Secondary ID
608898Useful For
Detecting clinically significant lead exposure due to occupational exposure
This test is not a substitute for blood lead screening.
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
PBOU | Lead Occupational Exposure | No | No |
CRETR | Creatinine, Random, U | No | No |
Special Instructions
Method Name
PBOU: Triple Quadrupole Inductively Coupled Plasm Mass Spectrometry (ICP-MS/MS)
CRETR: Enzymatic Colorimetric Assay
Reporting Name
Lead Occupat Exp, Random, USpecimen Type
UrineSpecimen Minimum Volume
1.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 14 days |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Clinical Information
Lead toxicity primarily affects the gastrointestinal, neurologic, and hematopoietic systems. Increased urine lead concentration per gram of creatinine indicates significant lead exposure. Measurement of urine lead concentration per gram of creatinine before and after chelation therapy has been used as an indicator of significant lead exposure. However, the American College of Medical Toxicology (ACMT 2010) position statement on post-chelator challenge urinary metal testing states that "post-challenge urinary metal testing has not been scientifically validated, has no demonstrated benefit, and may be harmful when applied in the assessment and treatment of patients in whom there is concern for metal poisoning.
Lead blood measurement is the best test for clinical correlation of toxicity. For more information see PBDV / Lead, Venous, with Demographics, Blood.
Reference Values
LEAD/CREATININE:
Biological Exposure Index (BEI): <150 mcg/g creatinine
CREATININE:
≥18 years: 16-326 mg/dL
Reference values have not been established for patients who are younger than 18 years of age.
Interpretation
Measurements of urinary lead levels have been used to assess lead exposure. However, like blood lead, urinary lead excretion mainly reflects recent exposure and, thus, shares many of the same limitations for assessing lead body burden or long-term exposure.(1,2)
Urinary lead concentration increases exponentially with blood lead and can exhibit relatively high intra-individual variability, even at similar blood lead concentrations.(3,4)
CPT Code Information
83655
82570
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PBUOE | Lead Occupat Exp, Random, U | 13466-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CRETR | Creatinine, Random, U | 2161-8 |
608894 | Lead Occupational Exposure | 13466-8 |